PTCT · PTC Therapeutics, Inc.

Summary

PTC Therapeutics, Inc. filed an 8-K on February 19, 2026, disclosing results of operations under Item 2.02 and Regulation FD disclosure under Item 7.01. The Company will host a conference call at 4:30 p.m. eastern time on that date, as previously announced, with Exhibit 99.1 being the related press release.

Key takeaways

• Item 2.02: Results of Operations disclosed.
• Item 7.01: Regulation FD Disclosure.
• Conference call scheduled for February 19, 2026 at 4:30 p.m. eastern time.
• Exhibit 99.1: Press Release dated February 19, 2026.